[
  {
    "ts": null,
    "headline": "ClearBridge All Cap Growth Portfolios Q4 2024 Commentary",
    "summary": "Despite inklings of a market broadening sparked by Donald Trumpâs election victory and further interest rate cuts from the Fed, the post-election rally proved short-lived.",
    "url": "https://finnhub.io/api/news?id=832a9b4407a105064fc1cfb530dbd13f63fb60b6b2405433153447afc3b9240f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743116100,
      "headline": "ClearBridge All Cap Growth Portfolios Q4 2024 Commentary",
      "id": 133504109,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2182036952/image_2182036952.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Despite inklings of a market broadening sparked by Donald Trumpâs election victory and further interest rate cuts from the Fed, the post-election rally proved short-lived.",
      "url": "https://finnhub.io/api/news?id=832a9b4407a105064fc1cfb530dbd13f63fb60b6b2405433153447afc3b9240f"
    }
  },
  {
    "ts": null,
    "headline": "Putnam U.S. Small Cap Growth Equity Q4 2024 Commentary",
    "summary": "In a challenging quarter for small cap stocks, the portfolio underperformed its benchmark, the Russell 2000 Growth Index, based on gross and net returns.",
    "url": "https://finnhub.io/api/news?id=bb37aae6926f0931df4589b3d4affaef88834634fc199f697f881b661ea04de7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743115200,
      "headline": "Putnam U.S. Small Cap Growth Equity Q4 2024 Commentary",
      "id": 133504075,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1283342758/image_1283342758.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "In a challenging quarter for small cap stocks, the portfolio underperformed its benchmark, the Russell 2000 Growth Index, based on gross and net returns.",
      "url": "https://finnhub.io/api/news?id=bb37aae6926f0931df4589b3d4affaef88834634fc199f697f881b661ea04de7"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors",
    "summary": "Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=17f8cfcc751b0337dde4e37c185a645ae3b0e1f499d019ffb8e10563bf38e7b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743112816,
      "headline": "Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors",
      "id": 133505725,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex Pharmaceuticals (VRTX) closed at $502.55 in the latest trading session, marking a +0.45% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=17f8cfcc751b0337dde4e37c185a645ae3b0e1f499d019ffb8e10563bf38e7b7"
    }
  },
  {
    "ts": null,
    "headline": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
    "summary": "Jefferies analysts singled out the stocks that will be affected the most and the least by potential import taxes.",
    "url": "https://finnhub.io/api/news?id=f58df00bb20b8c43e492a2a40109df7467ae78a0e89aab182a4cab400cb2a554",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743085320,
      "headline": "Trump Weighs Tariffs on Pharma in Ireland. What It Means for Amgen, Gilead.",
      "id": 133481428,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Jefferies analysts singled out the stocks that will be affected the most and the least by potential import taxes.",
      "url": "https://finnhub.io/api/news?id=f58df00bb20b8c43e492a2a40109df7467ae78a0e89aab182a4cab400cb2a554"
    }
  },
  {
    "ts": null,
    "headline": "Franklin Biotechnology Discovery Fund Q4 2024 Commentary",
    "summary": "Franklin Biotechnology Discovery Fund Q4 2024 Commentary",
    "url": "https://finnhub.io/api/news?id=743b5137aca60badcb2ace1e5601b3a1d46e916bce67c484c60523c28bfb157b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743060600,
      "headline": "Franklin Biotechnology Discovery Fund Q4 2024 Commentary",
      "id": 133467152,
      "image": "",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=743b5137aca60badcb2ace1e5601b3a1d46e916bce67c484c60523c28bfb157b"
    }
  }
]